Literature DB >> 9286419

Dendritic cell based therapy of cancer.

M T Lotze1, M Shurin, I Davis, A Amoscato, W J Storkus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9286419     DOI： 10.1007/978-1-4757-9966-8_91

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.

Authors:  Weibo Cai; Zachary J Kerner; Hao Hong; Jiangtao Sun
Journal:  Biochem Insights       Date:  2008-07-22

2.  The establishment of dendritic cell-tumor fusion vaccines for hormone refractory prostate cancer cell.

Authors:  Tae-Beom Kim; Ho Ki Park; Joo Hyun Chang; In Ho Choi; Khae Hawn Kim; Sang Jin Yoon; Min Sung Lee; Han Jung; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2010-02-18

3.  Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells.

Authors:  Pawel Kalinski; Eva Wieckowski; Ravikumar Muthuswamy; Esther de Jong
Journal:  Methods Mol Biol       Date:  2010

Review 4.  Immunostimulatory DNA sequences and cancer therapy.

Authors:  G J Weiner
Journal:  Springer Semin Immunopathol       Date:  2000

5.  Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.

Authors:  Svetomir N Markovic; Allan B Dietz; Carl W Greiner; Mary L Maas; Greg W Butler; Douglas J Padley; Peggy A Bulur; Jacob B Allred; Edward T Creagan; James N Ingle; Dennis A Gastineau; Stanimir Vuk-Pavlovic
Journal:  J Transl Med       Date:  2006-08-15       Impact factor: 5.531

6.  Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.

Authors:  E E Hillenbrand; A M Neville; B J Coventry
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.